Evolving landscape of neuroendocrine tumor disease Predicting tumor behaviour u...
Evolving landscape of neuroendocrine tumor disease Predicting tumor behaviour using metabolic profiling
Background: Tumors that arise from neuroendocrine cells (NENs) were traditionally considered rare tumors with low malignant potential. Recent data suggest that the incidence of NENs has increased over the last three decades. Furth...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2017-89229-R
CONTRIBUCIONES DE LA METABOLOMICA POR RMN A LA CLASIFICACION...
169K€
Cerrado
RTC-2016-5674-1
Determinación de perfiles metabolómicos en el diagnóstico pr...
482K€
Cerrado
FUTUGEMET
Functional tumour genomics using metabolomic profiling
181K€
Cerrado
PID2021-126543OB-C22
PROCESADO DE SEÑAL EN METABOLOMICA CUANTITATIVA DIRIGIDA Y D...
182K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Background: Tumors that arise from neuroendocrine cells (NENs) were traditionally considered rare tumors with low malignant potential. Recent data suggest that the incidence of NENs has increased over the last three decades. Furthermore, symptoms are frequently overlooked and subsequently, 60-80% of these tumors present with metastases at initial diagnosis. The common denominator of these tumors is their neuroendocrine origin; however, they demonstrate remarkable diversity, unique properties and different survival rates. We have little knowledge regarding the fundamental regulators of proliferation of these tumors and, hence, we have a narrow range of treatment options. We need additional biological and molecular data to enhance our knowledge on NENs, optimize patient stratification according to prognosis and to develop a more successful treatment strategy. Metabonomics is an emerging research field that provides an insight into the metabolic pathways of living cells. It represents a promising tool for better understanding of genetic data, for establishing a metabolic signature and for interpreting epidemiology in the cell level by metabolic screening.
Aim: The aim of this study is to develop a metabolic signature of NENs that would allow stratification according to the primary tumor site and the malignant potential. We will also try to investigate the reported increase of NENs incidence.
Methods: Patients with neuroendocrine tumors will be included in the study. Spectroscopy and spectrometry techniques will be used for the development of a metabonomic profile.
Relevance to the work programme: This project will allow the experienced researcher to attain a higher level of training in the management of NENs and to be exposed to the field of metabonomics. The expected impact of the acquired additional skills and knowledge for the researcher is to enhance his academic profile and strengthen his ability to obtain an academic post in the country of his origin.